Skip to main content

8 Result(s)

within C J Heuck Remove this filter

and

  1. Article

    Erratum: Dose-dense and less dose-intense total therapy 5 for gene expression profiling-defined high-risk multiple myeloma

    Correction to: Blood Cancer Journal (2016) 6, e453; doi:10.1038/bcj.2016.64 The purpose of this corrigendum is to publish grant support omitted in the manuscript 16-BCJ-0175T entitled, ‘Dose-dense and less dos...

    Y Jethava, A Mitchell, M Zangari, S Waheed, C Schinke… in Blood Cancer Journal (2016)

    Download PDF (66 KB) View Article

  2. Article

    Open Access

    Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma

    Multiple myeloma (MM) is a heterogeneous disease with high-risk patients progressing rapidly despite treatment. Various definitions of high-risk MM are used and we reported that gene expression profile (GEP)-d...

    Y Jethava, A Mitchell, M Zangari, S Waheed, C Schinke… in Blood Cancer Journal (2016)

    Download PDF (1129 KB) View Article

  3. Article

    Open Access

    Inhibiting MEK in MAPK pathway-activated myeloma

    C J Heuck, Y Jethava, R Khan, F van Rhee, M Zangari, S Chavan, K Robbins… in Leukemia (2016)

    Download PDF (2001 KB) View Article

  4. No Access

    Article

    Clinical value of molecular subty** multiple myeloma using gene expression profiling

    Using a data set of 1217 patients with multiple myeloma enrolled in Total Therapies, we have examined the impact of novel therapies on molecular and risk subgroups and the clinical value of molecular classific...

    N Weinhold, C J Heuck, A Rosenthal, S Thanendrarajan, C K Stein, F Van Rhee… in Leukemia (2016)

  5. No Access

    Article

    Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma

    S W Erickson, O W Stephens, S S Chavan, E Tian, J Epstein, B Barlogie… in Leukemia (2015)

  6. Article

    Open Access

    Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma

    C J Heuck, P Qu, F van Rhee, S Waheed, S Z Usmani, J Epstein, Q Zhang… in Leukemia (2014)

    Download PDF (639 KB) View Article

  7. No Access

    Article

    Hematopoietic progenitor cell collection after autologous transplant for multiple myeloma: low platelet count predicts for poor collection and sole use of resulting graft enhances risk of myelodysplasia

    Collection of hematopoietic progenitor cells (HPC) after previous autologous hematopoietic progenitor cell transplant (aHCT) was studied in 221 patients with multiple myeloma (MM). With a total of 333 collecti...

    X Papanikolaou, E R Rosenbaum, L N Tyler, J Sawyer, C J Heuck, B Barlogie… in Leukemia (2014)

  8. No Access

    Article

    Primary plasma cell leukemia: clinical and laboratory presentation, gene-expression profiling and clinical outcome with Total Therapy protocols

    To determine whether primary plasma cell leukemia (PPCL) remains a high-risk multiple myeloma feature in the context of contemporary therapy and gene-expression profiling (GEP), we reviewed records of 1474 pat...

    S Z Usmani, B Nair, P Qu, E Hansen, Q Zhang, N Petty, S Waheed… in Leukemia (2012)